CN Patent

CN1759834B — 黄连素或其与辛伐他汀联合在制备用于预防或治疗与血脂有关疾病或症状的产品中用途

Assigned to Institute of Medicinal Biotechnology of CAMS and PUMC · Expires 2010-06-23 · 16y expired

What this patent protects

本发明涉及黄连素或其与辛伐他汀联合在制备用于预防和/或治疗与高血脂有关疾病或症状的产品中用途。本发明还涉及用于预防和/或治疗与血脂有关疾病或症状的产品，其包括黄连素或黄连素与辛伐他汀和/或赋形剂或载体。

USPTO Abstract

本发明涉及黄连素或其与辛伐他汀联合在制备用于预防和/或治疗与高血脂有关疾病或症状的产品中用途。本发明还涉及用于预防和/或治疗与血脂有关疾病或症状的产品，其包括黄连素或黄连素与辛伐他汀和/或赋形剂或载体。

Drugs covered by this patent

Patent Metadata

Patent number
CN1759834B
Jurisdiction
CN
Classification
—
Expires
2010-06-23
Drug substance claim
No
Drug product claim
No
Assignee
Institute of Medicinal Biotechnology of CAMS and PUMC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.